A detailed history of Potomac Fund Management Inc /Adv transactions in Eli Lilly & CO stock. As of the latest transaction made, Potomac Fund Management Inc /Adv holds 519 shares of LLY stock, worth $530,262. This represents 0.02% of its overall portfolio holdings.

Number of Shares
519
Previous 372 39.52%
Holding current value
$530,262
Previous $294 Million 34.68%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$625.65 - $812.69 $91,970 - $119,465
147 Added 39.52%
519 $396 Million
Q2 2025

Oct 02, 2025

BUY
$713.71 - $898.95 $18,556 - $23,372
26 Added 7.51%
372 $294 Million
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $18,556 - $23,372
26 Added 7.51%
372 $294 Million
Q1 2025

Oct 02, 2025

SELL
$725.72 - $929.72 $18,868 - $24,172
-26 Reduced 6.99%
346 $283 Million
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $251,099 - $321,683
346 New
346 $283 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Potomac Fund Management Inc /Adv Portfolio

Follow Potomac Fund Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Potomac Fund Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Potomac Fund Management Inc /Adv with notifications on news.